Background A third of older people take five or more regular medications (polypharmacy).
Conducting medication reviews in primary care is key to identify and reduce/stop …

Background Mixed findings about deprescribing impact have emerged from varied study
designs, interventions, outcome measures and targeting sub-categories of medications or …

The concept of polypharmacy encompasses adverse drug reactions and non-adherence
factors in elderly individuals. It also leads to the increased use of healthcare services and …

(1) Background: A pharmacist-led deprescribing service previously developed within the
Consultation-Based Palliative Care Team (CB-PCT) was implemented for terminal cancer …

Polypharmacy (PP) is a common problem in modern medicine, especially known to affect
patients with chronic diseases such as multiple sclerosis (MS). With an increasing number of …

Background Deprescribing is an integral part of patient care. The term'deprescribing'may be
new to some, but the concept is not. Deprescribing refers to the planned withdrawal of …

Background: Current treatment guidelines advise that the deprescribing of antidepressants
should occur around 6 months post-remission of symptoms. However, this is not routinely …

Background: Research suggests that the rapid increase in worldwide antidepressant use is
mainly due to a rise in long-term and potentially inappropriate use. It has been suggested …

Background Current benzodiazepine (BZD) prescription guidelines recommend short-term
use to minimize the risk of dependence, cognitive impairment, and falls and fractures …

Background Polypharmacy and potentially inappropriate medicine use is common in older
people, resulting in harm increased by lack of patient-centred care. Hospital clinical …